Stocks
Sino Biopharmaceutical Limited (SBMFF) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -0.18 | -0.44 | -0.22 | -0.79 | -0.83 | -1.37 | |||
| Changes by years, y/y, % | -42% | +137% | -50% | +258% | +6% | +21.2% | |||
Sino Biopharmaceutical Limited. Debt/EBITDA
Sino Biopharmaceutical Limited. Debt/EBITDA, changes, %
Sino Biopharmaceutical Limited (SBMFF) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q4 | LTM ? | |||
| Debt/EBITDA | -0.70 | -0.79 | -1.29 | -1.29 | -1.13 | -1.37 | ||
| Changes by years, y/y, % | +203% | +225% | +147% | +179% | +43% | |||
| Changes by quarters, q/q, % | +52% | +12% | +64% | +0% | -12% | |||
